Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study

Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study Obesity has long been associated with endometrial cancer. However, there is a paucity of studies addressing the impact of morbid obesity in type II endometrial cancer on oncologic and surgical outcomes. In this study, the author retrospectively compared morbid to non-morbid obese in clinico-epidemiologic, surgical, and oncologic outcomes. Both groups were comparable as regards all clinico-epidemiologic parameters. Vaginal involvement, survival, and recurrence were also comparable between the 2 groups. Para-aortic adenopathy and treatment with preoperative therapy were the only significant predictors of DFS. Surgery is feasible with equivalent complications and oncologic outcomes in morbidly obese patients with type II endometrial cancer. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Indian Journal of Surgical Oncology Springer Journals

Impact of Morbid Obesity on the Outcomes of Type II Endometrial Cancer: a Cohort Study

Download PDF
6 pages

Loading next page...
 
/lp/springer-journals/impact-of-morbid-obesity-on-the-outcomes-of-type-ii-endometrial-cancer-tQBoTW6Tvc
Publisher
Springer Journals
Copyright
Copyright © Indian Association of Surgical Oncology 2022
ISSN
0975-7651
eISSN
0976-6952
DOI
10.1007/s13193-022-01503-z
Publisher site
See Article on Publisher Site

Abstract

Obesity has long been associated with endometrial cancer. However, there is a paucity of studies addressing the impact of morbid obesity in type II endometrial cancer on oncologic and surgical outcomes. In this study, the author retrospectively compared morbid to non-morbid obese in clinico-epidemiologic, surgical, and oncologic outcomes. Both groups were comparable as regards all clinico-epidemiologic parameters. Vaginal involvement, survival, and recurrence were also comparable between the 2 groups. Para-aortic adenopathy and treatment with preoperative therapy were the only significant predictors of DFS. Surgery is feasible with equivalent complications and oncologic outcomes in morbidly obese patients with type II endometrial cancer.

Journal

Indian Journal of Surgical Oncology – Springer Journals

Published: Sep 1, 2022

Keywords: Endometrial cancer; Hysterectomy; Obesity Non-endometrioid carcinoma

References

  • Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
    Reeves, GK; Pirie, K; Beral, V; Green, J; Spencer, E; Bull, D
  • Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
    Calle, EE; Kaaks, R
  • Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
    Renehan, AG; Tyson, M; Egger, M; Heller, RF; Zwahlen, M
  • Mini-laparotomy versus vaginal surgery for class II-III obese patients with early-stage endometrial cancer
    Fambrini, M; Pieralli, A; Bitossi, U
  • Treatment modalities in endometrial cancer
    Amant, F; Moerman, P; Neven, P; Timmerman, D; Van Limbergen, E; Vergote, I
  • Laparoscopy or laparotomy? A comparison of 240 patients with early-stage endometrial cancer
    Santi, A; Kuhn, A; Gyr, T
  • Molecular and pathologic aspects of endometrial carcinogenesis
    Hecht, JL; Mutter, GL
  • Endometrial carcinoma: pathology and genetics
    Prat, J; Gallardo, A; Cuatrecasas, M; Catasús, L
  • Two pathogenetic types of endometrial carcinoma
    Bokhman, JV
  • Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma
    Hendrickson, M; Ross, J; Eifel, P; Martinez, A; Kempson, R
  • Stage II uterine papillary serous carcinoma: carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes
    Fader, AN; Nagel, C; Axtell, AE
  • An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
    Fader, AN; Starks, D; Gehrig, PA
  • The association between metabolic abnormality and endometrial cancer: a large case-control study in China
    Zhang, Y; Liu, Z; Yu, X
  • Type I and II endometrial cancers: have they different risk factors?
    Setiawan, VW; Yang, HP; Pike, MC
  • Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype
    McCullough, ML; Patel, AV; Patel, R
  • Body size in relation to cancer of the uterine corpus in 1 million Norwegian women
    Bjørge, T; Engeland, A; Tretli, S; Weiderpass, E
  • Health effects of overweight and obesity in 195 countries over 25 years
    Afshin, A; Forouzanfar, MH; Reitsma, MB
  • Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients
    Pavelka, JC; Ben-Shachar, I; Fowler, JM
  • Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia
    Giugale, LE; Di Santo, N; Smolkin, ME; Havrilesky, LJ; Modesitt, SC
  • Obesity and perioperative outcomes in endometrial cancer surgery
    Santoso, JT; Barton, G; Riedley-Malone, S; Wan, JY
  • Obesity as a risk factor of in-hospital outcomes in patients with endometrial cancer treated with traditional surgical mode
    Januszek, SM; Barnas, E; Skret-Magierlo, J
  • Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer
    Akbayır, O; Corbacıoglu Esmer, A; Numanoglu, C
  • Long-term follow-up after laparoscopic management of endometrial cancer in the obese: a fifteen-year cohort study
    Rabischong, B; Larraín, D; Canis, M
  • Impact of morbid obesity in surgical management of endometrial cancer: surgical morbidity, clinical and pathological aspects
    Erkanli, S; Kayaselçuk, F; Bagis, T; Kuşçu, E
  • Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer
    Watari, H; Todo, Y; Takeda, M; Ebina, Y; Yamamoto, R; Sakuragi, N
  • Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium
    Lurain, JR; Rice, BL; Rademaker, AW; Poggensee, LE; Schink, JC; Miller, DS
  • Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study
    Morrow, CP; Bundy, BN; Kurman, RJ
  • Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women
    Jeong, N-H; Lee, J-M; Lee, J-K
  • Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study
    Modesitt, SC; Tian, C; Kryscio, R